A cancer diagnosis has hit very close to home in recent months. It’s likely that cancer has also struck close to most of ...

A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...

It took a decade for Heather Castellani Milboer to be diagnosed with multiple sclerosis. Now, she helps build community for ...

In line with MS Awareness Month, the National Multiple Sclerosis Society (NMSS) in collaboration with Snap, has launched its ...

Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...

Dimika V. Cavalier shares details of her long MS diagnosis journey and the eventual acceptance of her new normal.

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...

Dr Pavan Bhargava anticipates updates on diagnostic criteria, MRI techniques, biomarkers, treatments, and the role of diet in ...

Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...

The impact of senescent cells on remyelination is unknown. Here, the authors show that treatment with senolytics following demyelination enhances remyelination in young, but not aged mice, and ...